Page last updated: 2024-08-16

pirinixic acid and thromboplastin

pirinixic acid has been researched along with thromboplastin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chinetti, G; Corseaux, D; Duriez, P; Fruchart, JC; Jude, B; Neve, BP; Staels, B; Zawadzki, C1
Hombach, V; Libby, P; Mackman, N; Marx, N; Plutzky, J; Schönbeck, U; Yilmaz, N1
Huang, TH; Li, Y; Roufogalis, BD; Tran, VH1

Other Studies

3 other study(ies) available for pirinixic acid and thromboplastin

ArticleYear
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages.
    Circulation, 2001, Jan-16, Volume: 103, Issue:2

    Topics: Butyrates; Cells, Cultured; Down-Regulation; Fenofibrate; Humans; Interleukin-1; Lipopolysaccharides; Macrophages; Monocytes; Peroxisome Proliferators; Phenylurea Compounds; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thromboplastin; Transcription Factors

2001
PPARalpha activators inhibit tissue factor expression and activity in human monocytes.
    Circulation, 2001, Jan-16, Volume: 103, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Cells, Cultured; DNA; Humans; Lipopolysaccharides; Macrophages; Monocytes; NF-kappa B; Peroxisome Proliferators; Promoter Regions, Genetic; Proto-Oncogene Proteins c-rel; Pyrimidines; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thromboplastin; Transcription Factor RelA; Transcription Factors; Tumor Necrosis Factor-alpha

2001
Gypenoside XLIX, a naturally occurring gynosaponin, PPAR-alpha dependently inhibits LPS-induced tissue factor expression and activity in human THP-1 monocytic cells.
    Toxicology and applied pharmacology, 2007, Jan-01, Volume: 218, Issue:1

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Cardiovascular Agents; Cell Line; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gynostemma; Humans; Indoles; Lipopolysaccharides; Monocytes; NF-kappa B; Peroxisome Proliferators; PPAR alpha; Promoter Regions, Genetic; Pyrimidines; Pyrrolidines; RNA, Messenger; Saponins; Thiocarbamates; Thromboplastin; Transcription, Genetic; Transfection

2007